The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Duloxetine Krka 30mg hard gastro-resistant capsule

30 milligram(s) Gastro-resistant capsule

KRKA, d.d., Novo mestoPA1347/051/002

Main Information

Trade NameDuloxetine Krka 30mg hard gastro-resistant capsule
Active SubstancesDuloxetine
Strength30 milligram(s)
Dosage FormGastro-resistant capsule
Licence HolderKRKA, d.d., Novo mesto
Licence NumberPA1347/051/002

Group Information

ATC CodeN06AX Other antidepressants
N06AX21 duloxetine

Status

Authorised/WithdrawnAuthorised
Licence Issued13/03/2015
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0091-033-006
Interchangeable List DocumentPDF of Interchangeable List
« Back